Astaxanthin Alleviates Foam Cell Formation and Promotes Cholesterol Efflux in Ox-LDL-Induced RAW264.7 Cells via CircTPP2/miR-3073b-5p/ABCA1 Pathway. 2023

Zhexiao Zhang, and Yunmei Qiu, and Wanzhi Li, and Anyang Tang, and Hang Huang, and Wanyi Yao, and Huawen Li, and Tangbin Zou
The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan 523710, China.

Atherosclerosis (AS) is a common cardiovascular disease and remains the leading cause of death in the world. It is generally believed that the deposition of foam cells in the arterial wall is the main cause of AS. Moreover, promoting cholesterol efflux and enhancing the ability of reverse cholesterol transport (RCT) can effectively inhibit the formation of foam cells, thereby preventing the occurrence and development of AS. Astaxanthin, with a powerful antioxidant ability, has a potential role in the prevention of atherosclerosis, but how it works in preventing atherosclerosis remains unknown. Here, our experimental results suggest that astaxanthin can upregulate the expression of circular RNA tripeptidyl-peptidase II (circTPP2) and eventually promote cholesterol efflux by modulating ATP-binding cassette subfamily A member 1 (ABCA1). The expression of ABCA1 was significantly suppressed after knocking down circTPP2 in macrophage-derived foam cells. In addition, the experimental results showed that circTPP2 could downregulate the expression of microRNA-3073b-5p (miR-3073b-5p), and ABCA1 was identified as the target gene of miR-3073b-5p. In conclusion, the circTPP2/miR-3073b-5p/ABCA1 axis may be the specific mechanism of astaxanthin promoting cholesterol efflux.

UI MeSH Term Description Entries
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D005487 Foam Cells Lipid-laden macrophages originating from monocytes or from smooth muscle cells. Cell, Foam,Cells, Foam,Foam Cell
D000067996 RAW 264.7 Cells A transformed macrophage cell line isolated from ASCITES of mice infected with ABELSON MURINE LEUKEMIA VIRUS. RAW 264.7 Cell Line,264.7 Cell, RAW,264.7 Cells, RAW,Cell, RAW 264.7,Cells, RAW 264.7,RAW 264.7 Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D050197 Atherosclerosis A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA. Atherogenesis,Atherogeneses,Atheroscleroses
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA
D064286 ATP Binding Cassette Transporter 1 A superfamily of integral ATP-binding cassette membrane proteins whose expression pattern is consistent with a role in lipid (cholesterol) efflux. It is implicated in TANGIER DISEASE, characterized by accumulation of cholesteryl ester in various tissues. ABCA1 Protein,ATP Binding Cassette Transporter, Subfamily A, Member 1,ATP-Binding Cassette Sub-Family A Member 1,CERP Protein,Cholesterol-Efflux Regulatory Protein,ATP Binding Cassette Sub Family A Member 1,Cholesterol Efflux Regulatory Protein

Related Publications

Zhexiao Zhang, and Yunmei Qiu, and Wanzhi Li, and Anyang Tang, and Hang Huang, and Wanyi Yao, and Huawen Li, and Tangbin Zou
January 2023, Frontiers in pharmacology,
Zhexiao Zhang, and Yunmei Qiu, and Wanzhi Li, and Anyang Tang, and Hang Huang, and Wanyi Yao, and Huawen Li, and Tangbin Zou
January 2019, Life sciences,
Zhexiao Zhang, and Yunmei Qiu, and Wanzhi Li, and Anyang Tang, and Hang Huang, and Wanyi Yao, and Huawen Li, and Tangbin Zou
March 2020, Biochemical and biophysical research communications,
Zhexiao Zhang, and Yunmei Qiu, and Wanzhi Li, and Anyang Tang, and Hang Huang, and Wanyi Yao, and Huawen Li, and Tangbin Zou
April 2021, Inflammation,
Zhexiao Zhang, and Yunmei Qiu, and Wanzhi Li, and Anyang Tang, and Hang Huang, and Wanyi Yao, and Huawen Li, and Tangbin Zou
October 2018, European review for medical and pharmacological sciences,
Zhexiao Zhang, and Yunmei Qiu, and Wanzhi Li, and Anyang Tang, and Hang Huang, and Wanyi Yao, and Huawen Li, and Tangbin Zou
January 2024, Journal of ethnopharmacology,
Zhexiao Zhang, and Yunmei Qiu, and Wanzhi Li, and Anyang Tang, and Hang Huang, and Wanyi Yao, and Huawen Li, and Tangbin Zou
August 2021, Experimental and therapeutic medicine,
Zhexiao Zhang, and Yunmei Qiu, and Wanzhi Li, and Anyang Tang, and Hang Huang, and Wanyi Yao, and Huawen Li, and Tangbin Zou
October 2023, BMC cardiovascular disorders,
Zhexiao Zhang, and Yunmei Qiu, and Wanzhi Li, and Anyang Tang, and Hang Huang, and Wanyi Yao, and Huawen Li, and Tangbin Zou
May 2017, The FEBS journal,
Zhexiao Zhang, and Yunmei Qiu, and Wanzhi Li, and Anyang Tang, and Hang Huang, and Wanyi Yao, and Huawen Li, and Tangbin Zou
May 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Copied contents to your clipboard!